*Citations A 68-week clinical trial evaluated the efficacy of a treatment plan consisting of 2.4 mg semaglutide, reducedcalorie diet, and increased physical activity. Patients with a BMI of 30 or 27 with comorbidities but without diabetes achieved 15-20% average weight loss within a year (study).